Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road ...

Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a ...

In short, this research could lead to life-saving changes in how ILD is diagnosed and treated. By catching the disease early ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.

Researchers at UVA Health are working on a new way to detect a serious lung disease before it becomes dangerous. The disease, ...

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, ...

The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with idiopathic pulmonary ...

Real-world use of antifibrotic therapy is associated with greater estimated survival in pulmonary fibrosis interstitial lung disease (PF-ILD).

Tvardi Therapeutics has failed its first big test as a public company. | Tvardi Therapeutics has failed its first big test as a public company. Months after joining Nasdaq, the biotech has reported ...

In this week’s edition of InnovationRx, we look at Town Hall Ventures’ $440 million haul, the CDC’s “Friday night massacre,” ...